SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019687-08-002782
Filing Date
2008-06-19
Accepted
2008-06-19 18:59:42
Documents
1
Period of Report
2008-04-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 5  
1 PRIMARY DOCUMENT edgar.xml 5 4907
  Complete submission text file 0001019687-08-002782.txt   6831
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Issuer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1

Mailing Address
Business Address 10875 FEMAH LANE SAN DIEGO CA 92131
POHL DAVID (Reporting) CIK: 0001233396 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-32839 | Film No.: 08908676